Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Holding ANIP?
Track your performance easily
ANI Pharmaceuticals (ANIP) Ownership Overview
10.07% Insiders
17.62% Mutual Funds
23.72% Other Institutional Investors
22.67% ETFs
25.92% Public Companies and
Individual Investors
The ownership structure of ANI Pharmaceuticals (ANIP) stock is a mix of institutional, retail, and individual investors. Approximately 64.01% of the company’s stock is owned by Institutional Investors, 10.07% is owned by Insiders, and 25.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 18, 2024 | Stephen P. Carey Svp & Cfo | xxxxxxxxxxxxx | $418425 |
| Nov 27, 2024 | Nikhil Lalwani President & Ceo,director | xxxxxxxxxxxxx | $1941442 |
| Nov 18, 2024 | Christopher Mutz Head Of Rare Disease | xxxxxxxxxxxxx | $375050 |
| Jun 06, 2024 | Stephen P. Carey Svp & Cfo | xxxxxxxxxxxxx | $317900 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $357363 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $3107092 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $9336074 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,078,211 | Institution | 9.89% | 110,872,557 | |
| 1,080,788 | Institution | 5.14% | 57,660,040 | |
| 834,258 | Institution | 3.97% | 44,507,664 | |
| 706,272 | Insider | 3.36% | 37,679,611 | |
| 555,167 | Institution | 2.64% | 29,618,159 | |
| 370,378 | Insider | 1.76% | 19,759,666 | |
| 350,387 | Institution | 1.67% | 18,693,146 | |
| 336,396 | Institution | 1.60% | 17,946,727 | |
| 330,477 | Institution | 1.57% | 17,630,948 | |
| 326,067 | Institution | 1.55% | 17,395,674 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 834,258 | Institution | 3.97% | 44,507,664 | |
| 350,387 | Institution | 1.67% | 18,693,146 | |
| 336,396 | Institution | 1.60% | 17,946,727 | |
| 326,067 | Institution | 1.55% | 17,395,674 | |
| 209,738 | Institution | 1.00% | 11,189,522 | |
| 183,086 | Institution | 0.87% | 9,767,638 | |
| 162,932 | Institution | 0.78% | 8,692,422 | |
| 154,168 | Institution | 0.73% | 8,224,863 | |
| 117,888 | Institution | 0.56% | 6,289,325 | |
| 115,708 | Institution | 0.55% | 6,173,022 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,063,585 | Institution | 5.06% | 56,742,260 | |
| 589,094 | Institution | 2.80% | 33,722,686 | |
| 553,331 | Institution | 2.63% | 30,023,740 | |
| 520,462 | Institution | 2.48% | 27,766,648 | |
| 245,155 | Institution | 1.17% | 14,033,898 | |
| 165,837 | Institution | 0.79% | 8,847,404 | |
| 153,150 | Institution | 0.73% | 8,309,919 | |
| 129,566 | Institution | 0.62% | 6,912,346 | |
| 118,148 | Institution | 0.56% | 6,303,196 | |
| 91,358 | Institution | 0.43% | 4,957,085 |
FAQ
Who Owns ANI Pharmaceuticals Inc (ANIP)?
According to the latest TipRanks data, approximately 23.72% of the company's stock is held by institutional investors, 10.07% is held by insiders, and 25.92% is held by retail investors.
What percentage of ANI Pharmaceuticals Inc (ANIP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 23.72% of ANI Pharmaceuticals Inc (ANIP) stock is held by institutional investors.
What percentage of ANI Pharmaceuticals Inc (ANIP) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.92% of ANI Pharmaceuticals Inc (ANIP) stock is held by retail investors.
Who owns the most shares of ANI Pharmaceuticals Inc (ANIP)?
iShares owns the most shares of ANI Pharmaceuticals Inc (ANIP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.